The Effect of IV Cangrelor and Oral Ticagrelor Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02733341

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
The Royal Wolverhampton Hospitals NHS Trust (from the registry)
Registry
  • NCT NCT02733341
Other papers using this trial's data
  • Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial Thrombosis and haemostasis, 2019-07 DOI, PubMed 31129911

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02733341. Randomized; no masking; primary purpose treatment. Start 2016-07-21 (actual); primary completion 2018-10-01 (actual). Results posted on 2025-05-02.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of IV Cangrelor and Oral Ticagrelor Study
Condition
Acute Coronary Syndrome (ACS)
Condition
High On-treatment Platelet Reactivity (HTPR)
Condition
Microvascular Obstruction (MVO)
Condition
ST-segment Elevation Myocardial Infarction (STEMI)
Condition
Thrombolysis in Myocardial Infarction (TIMI)
Condition
Unstable Angina (UA)
Intervention (Drug)
Cangrelor
Intervention (Drug)
Ticagrelor
Lead sponsor
The Royal Wolverhampton Hospitals NHS Trust (class: other government)

Record details

Record id
cardio:ct-nct02733341
Content hash
c40b4091e696958d2c8d0ac4d865dc0b7efd07778c367085c8ab9719c58155ff